The long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertension
- 1 February 2000
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 129 (2) , 136-143
- https://doi.org/10.1016/s0002-9394(99)00343-8
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Clinical efficacy and safety of brinzolamide (Azopt™), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertensionAmerican Journal of Ophthalmology, 1998
- A Six-week Dose-response Study of the Ocular Hypotensive Effect of Dorzolamide With a One-year ExtensionAmerican Journal of Ophthalmology, 1996
- Standardizing the Measurement of Intraocular Pressure for Clinical ResearchOphthalmology, 1996
- Measurement of intraocular pressure: A study of its reproducibilityAlbrecht von Graefes Archiv für Ophthalmologie, 1976